Very impressive work!
Excited to share our new work from @GoogleDeepMind @GoogleResearch @GoogleForHealth. We trained LLMs for psychiatric intake using multi-turn RL with simulated patients. Amazing work led by @SRSchmidgall and leadership from @valentinlievin, Isaac Galatzer-Levy and David Racz. Incredibly proud to be a co-author on this study!👇
arxiv.org/abs/2610.40476
0
0
0
43
Patrick Wayte retweeted
Personalized healthcare will be disrupted big time with what agents are capable of today
Computer turned a shoulder MRI report into an interactive 3D explainer a patient can read.
From one anonymized radiology report, it placed all nine findings on a skeletal model, with six X-ray projections and a plain-language explanation of each.
86
62
708
52,879
Patrick Wayte retweeted
Superpower Peptides, v1:
- BPC-157: $149/month
- TB-500: $149/month
- MOTS-c: $199/month
Every one comes with:
- a free blood test covering 40+ biomarkers
- review by a licensed clinician who sets your protocol
- check-ins every 4 weeks
- ongoing clinical guidance in the d in the USA, with active ingredients from FDA-registered facilities and prescriptions filled by US-licensed pharmacies.
Epitalon, Oral BPC and Semax nasal spray are next.
- BPC-157: $149/month
- TB-500: $149/month
- MOTS-c: $199/month
Every one comes with:
- a free blood test covering 40+ biomarkers
- review by a licensed clinician who sets your protocol
- check-ins every 4 weeks
- ongoing clinical guidance in the d in the USA, with active ingredients from FDA-registered facilities and prescriptions filled by US-licensed pharmacies.
Epitalon, Oral BPC and Semax nasal spray are next.
I’m thrilled to announce Superpower Peptides!
For the first time, members can access prescribed peptide treatments alongside their bloodwork, clinical evaluation, and ongoing support to align with Superpower’s mission to deliver concierge health for the masses.
It took a supply chain with trusted pharmacy partners, third-party testing, clinical protocols shaped by leading doctors, and peptides produced in the USA to get here.
Superpower is redefining the relationship between you, your health data, and your care team.
Now, peptides are part of that system.
Pre-orders are open now, with the first orders shipping at the end of November.
👉🏽 superpower.com/peptides
Welcome to the new standard in peptides.
90
38
647
97,551
Patrick Wayte retweeted
@Walmart has spent more than 60 years helping Americans save money and live better. We built Base to do the same for home energy.
Today, Walmart and Base announced a strategic agreement and investment in Base. Starting Monday, Base’s energy products will be available at nd Sam’s Club locations.
corporate.walmart.com/news/2026/10/W…
Today, Walmart and Base announced a strategic agreement and investment in Base. Starting Monday, Base’s energy products will be available at nd Sam’s Club locations.
corporate.walmart.com/news/2026/10/W…
11
36
377
89,068
RT @Gwynne_Shotwell: Robert and I are thrilled that our gift of over 2 million shares of SpaceX stock will be distributed to children’s Tru…
0
3,747
0
Patrick Wayte retweeted
ANNOUNCING: Superpower Peptides.
Prescription peptide care, connected with your blood testing.
For the first time, Superpower brings prescribed peptide treatments together with membership, beginning with BPC-157, TB-500 and MOTS-c.
Each one comes with:
- Treatment prescribed by licensed providers
- Comprehensive blood testing
- Clinical evaluation
- Third-party testing
- Regular check-ins and lab monitoring
- Active ingredients from FDA-registered facilities
- Prescriptions filled by US-licensed pharmacies
Because access to peptides has often outpaced guidance.
Your health history, goals and baseline bloodwork are reviewed by a licensed clinician, who can then monitor your health throughout treatment.
We’ve been preparing for this moment.
Your can start your blood test today, and at the end of November, we’re bringing peptides to you.
Pre-orders are open now:
superpower.com/peptides
Prescription peptide care, connected with your blood testing.
For the first time, Superpower brings prescribed peptide treatments together with membership, beginning with BPC-157, TB-500 and MOTS-c.
Each one comes with:
- Treatment prescribed by licensed providers
- Comprehensive blood testing
- Clinical evaluation
- Third-party testing
- Regular check-ins and lab monitoring
- Active ingredients from FDA-registered facilities
- Prescriptions filled by US-licensed pharmacies
Because access to peptides has often outpaced guidance.
Your health history, goals and baseline bloodwork are reviewed by a licensed clinician, who can then monitor your health throughout treatment.
We’ve been preparing for this moment.
Your can start your blood test today, and at the end of November, we’re bringing peptides to you.
Pre-orders are open now:
superpower.com/peptides
124
127
1,579
570,725
Extraordinary to see what’s happening in this space… I look forward to trying this through @superpower!
I’m thrilled to announce Superpower Peptides!
For the first time, members can access prescribed peptide treatments alongside their bloodwork, clinical evaluation, and ongoing support to align with Superpower’s mission to deliver concierge health for the masses.
It took a supply chain with trusted pharmacy partners, third-party testing, clinical protocols shaped by leading doctors, and peptides produced in the USA to get here.
Superpower is redefining the relationship between you, your health data, and your care team.
Now, peptides are part of that system.
Pre-orders are open now, with the first orders shipping at the end of November.
👉🏽 superpower.com/peptides
Welcome to the new standard in peptides.
0
0
3
145
Exciting developments from @AbridgeHQ
got an early look at the @AbridgeHQ assistant last week
excited to try this product in medical genetics, where there's no shortage of complex, multi-party workflows:
- phenotyping a patient comprehensively (chart biopsy)
- ordering molecular testing (identifying the correct lab based on the desired test, quality/coverage, turn-around time)
- navigating payment (institutional vs. patient pay), including requesting hospital committee approvals
- chasing down results, and interpreting in real-time patient clinical and research contexts
0
0
1
36
Great idea and looks very useful!
I'm thrilled to bring &Truth out of stealth as its co-founder and Chief Science Officer. With a team I'm proud to be part of, we're setting out to specify and prove all the world's software correct and secure.
If you geek out over code people can understand and trust, join us!
0
0
0
26
Patrick Wayte retweeted
Hypertension remains a leading driver of preventable cardiovascular mortality, with persistent disparities across communities. There is an urgent need for prevention and equitable access to evidence-based care. The time to act is now.
doi.org/10.1016/j.ajpc…
#SDOH @AmJCardio
doi.org/10.1016/j.ajpc…
#SDOH @AmJCardio
0
2
4
244
Patrick Wayte retweeted
.@ouraring, @UCSDHealth collaborate to study GLP-1 outcomes using continuous smart ring data
bit.ly/3UtY5ZU
bit.ly/3UtY5ZU
0
1
5
514
Patrick Wayte retweeted
A new chapter in peptide medicine has just begun.
The US just made certain peptides (legally) accessible through compounding pharmacies.
The new HHS policy says:
- 6 peptides: BPC-157, TB-500, Epitalon, KPV, MOTS-c and Semax
- HHS does not intend to take enforcement action d pharmacy, Federal facility, or licensed physician compounding them
- the goal is to expand and improve patient access
- FDA's future rulemakings may propose adding some or all of these peptides to the 503A bulks list
We're talking about peptides like BPC-157 which has mostly been available through RUO channels.
Now 503A pharmacies can compound it for individuals with a prescription.
The idea is to allow pharmacies to compound certain peptides while the FDA figures out long-term rules.
This process could take a year or more.
But this is a meaningful step forward.
The US just made certain peptides (legally) accessible through compounding pharmacies.
The new HHS policy says:
- 6 peptides: BPC-157, TB-500, Epitalon, KPV, MOTS-c and Semax
- HHS does not intend to take enforcement action d pharmacy, Federal facility, or licensed physician compounding them
- the goal is to expand and improve patient access
- FDA's future rulemakings may propose adding some or all of these peptides to the 503A bulks list
We're talking about peptides like BPC-157 which has mostly been available through RUO channels.
Now 503A pharmacies can compound it for individuals with a prescription.
The idea is to allow pharmacies to compound certain peptides while the FDA figures out long-term rules.
This process could take a year or more.
But this is a meaningful step forward.
BREAKING: HHS just released a policy which makes 6 peptides accessible through compounding pharmacies (with a prescription).
We’re talking about BPC-157, TB-500, MOTS-c, Semax, Epitalon and KPV, which have mostly been available through the gray market.
The peptide era is here.
14
7
75
10,479
Patrick Wayte retweeted
"Developers are cooked. Blue collar is the only safe job now"
The devs who got cooked:
The devs who got cooked:
Our robots built this in the city of Almere: curved walls, different types of bricks and bonds, indented text.
Real world deployment, insane complexity, 100% of every brick done by our robots, with another 15 houses to come in the coming weeks.
48
286
4,753
288,209
Patrick Wayte retweeted
A new injectable gel can rebuild worn-out spinal discs instead of just masking the pain.
Doctors working with US company ReGelTec are testing an injectable gel called Hydrafil for people whose spinal discs have worn down with age.
The discs are the cushions between your dry out and flatten, they can cause years of back pain. Hydrafil is injected through a needle as a warm liquid, then firms up at body temperature into a water-rich, rubbery cushion that refills the damaged disc and restores its height.
In a study of 60 patients, average back pain scores fell from 7.3 to 2.1 out of 10 after a year, and disability scores dropped sharply too.
Today, most treatments for worn discs manage symptoms with painkillers, injections or physical therapy, and the last resort is surgery to fuse or replace the disc. A gel that rebuilds the cushion itself could offer something in between.
The early study had no comparison group, and five patients needed a procedure to remove gel that had shifted. A larger trial against a placebo procedure is underway, and the FDA has granted it Breakthrough Device status to speed its review.
source: Clerk-Lamalice, O., et al. Pain Physician. As reported in Injectable gel rehydrates collapsed spinal discs. Engineerine.
Doctors working with US company ReGelTec are testing an injectable gel called Hydrafil for people whose spinal discs have worn down with age.
The discs are the cushions between your dry out and flatten, they can cause years of back pain. Hydrafil is injected through a needle as a warm liquid, then firms up at body temperature into a water-rich, rubbery cushion that refills the damaged disc and restores its height.
In a study of 60 patients, average back pain scores fell from 7.3 to 2.1 out of 10 after a year, and disability scores dropped sharply too.
Today, most treatments for worn discs manage symptoms with painkillers, injections or physical therapy, and the last resort is surgery to fuse or replace the disc. A gel that rebuilds the cushion itself could offer something in between.
The early study had no comparison group, and five patients needed a procedure to remove gel that had shifted. A larger trial against a placebo procedure is underway, and the FDA has granted it Breakthrough Device status to speed its review.
source: Clerk-Lamalice, O., et al. Pain Physician. As reported in Injectable gel rehydrates collapsed spinal discs. Engineerine.
68
398
2,448
104,369
Patrick Wayte retweeted
A Chicago-based financial giant with $85.9 billion in assets under management is planting its flag in Dallas. bizjournals.com/dallas/news/20…
1
1
7
3,096
Patrick Wayte retweeted
BREAKING: Tennessee senator wants The Boring Company to expand to Wilson County.
Sen. Mark Pody wants a Music City Loop extension to help ease traffic, paid for through private investment.
Great to see The Boring Company’s bold ideas winning more support. Keep digging!
Sen. Mark Pody wants a Music City Loop extension to help ease traffic, paid for through private investment.
Great to see The Boring Company’s bold ideas winning more support. Keep digging!
71
192
1,213
50,822
Patrick Wayte retweeted
Today, we’re introducing the next chapter of Concurrence and the world’s greatest leap toward Superintelligent Care.
When I was 13 I lost my mom to cancer that should’ve been caught earlier.
We’re building a system that sees every patient’s future in time to change the outcome
When I was 13 I lost my mom to cancer that should’ve been caught earlier.
We’re building a system that sees every patient’s future in time to change the outcome
164
146
1,500
1,569,801
Patrick Wayte retweeted
“If we can predict the [protein's] shape, we can design a drug that recognizes the harmful form and leaves the healthy one alone.”
A Hopkins-led team backed by up to $52M from @ARPA_H will build an AI model to decode how proteins misfold in Parkinson’s, cancer, and other diseases. bit.ly/4zMyCdb
A Hopkins-led team backed by up to $52M from @ARPA_H will build an AI model to decode how proteins misfold in Parkinson’s, cancer, and other diseases. bit.ly/4zMyCdb
19
123
680
78,949